Abstract
As diabetes technologies continue to advance, their use is expanding beyond type 1 diabetes to include populations with type 2 diabetes, older adults, pregnant individuals, those with psychiatric conditions, and hospitalized patients. This review examines the psychosocial outcomes of these technologies across these diverse groups, with a focus on treatment satisfaction, quality of life, and self-management behaviors. Despite demonstrated benefits in glycemic outcomes, the adoption and sustained use of these technologies face unique challenges in each population. By highlighting existing research and identifying gaps, this review seeks to emphasize the need for targeted studies and tailored support strategies to understand and optimize psychosocial outcomes and well-being.
Original language | English (US) |
---|---|
Pages (from-to) | 34-46 |
Number of pages | 13 |
Journal | Journal of Diabetes Science and Technology |
Volume | 19 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2025 |
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: MSH receives support through the National Institute of Diabetes and Digestive and Kidney Diseases (grants 1K23DK138267 and P30DK116074). ERF receives support through the National Institute of Nursing Research (grant K23NR020051). ARK receives support through the National Institute on Aging, National Institutes of Health (grant K01AG084971). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Keywords
- diabetes and mental health
- diabetes in pregnancy
- inpatient diabetes management
- older adults with diabetes
- psychosocial impacts of diabetes technology
- type 2 diabetes
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Bioengineering
- Biomedical Engineering